Cargando…

CD32(+) and PD-1(+) Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals

A recent study conducted in blood has proposed CD32 as the marker identifying the “elusive” HIV reservoir. We have investigated the distribution of CD32(+) CD4 T cells in blood and lymph nodes (LNs) of HIV-1-uninfected subjects and viremic untreated and long-term-treated HIV-1-infected individuals a...

Descripción completa

Detalles Bibliográficos
Autores principales: Noto, Alessandra, Procopio, Francesco A., Banga, Riddhima, Suffiotti, Madeleine, Corpataux, Jean-Marc, Cavassini, Matthias, Riva, Agostino, Fenwick, Craig, Gottardo, Raphael, Perreau, Matthieu, Pantaleo, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158413/
https://www.ncbi.nlm.nih.gov/pubmed/29976671
http://dx.doi.org/10.1128/JVI.00901-18
_version_ 1783358420358791168
author Noto, Alessandra
Procopio, Francesco A.
Banga, Riddhima
Suffiotti, Madeleine
Corpataux, Jean-Marc
Cavassini, Matthias
Riva, Agostino
Fenwick, Craig
Gottardo, Raphael
Perreau, Matthieu
Pantaleo, Giuseppe
author_facet Noto, Alessandra
Procopio, Francesco A.
Banga, Riddhima
Suffiotti, Madeleine
Corpataux, Jean-Marc
Cavassini, Matthias
Riva, Agostino
Fenwick, Craig
Gottardo, Raphael
Perreau, Matthieu
Pantaleo, Giuseppe
author_sort Noto, Alessandra
collection PubMed
description A recent study conducted in blood has proposed CD32 as the marker identifying the “elusive” HIV reservoir. We have investigated the distribution of CD32(+) CD4 T cells in blood and lymph nodes (LNs) of HIV-1-uninfected subjects and viremic untreated and long-term-treated HIV-1-infected individuals and their relationship with PD-1(+) CD4 T cells. The frequency of CD32(+) CD4 T cells was increased in viremic compared to treated individuals in LNs, and a large proportion (up to 50%) of CD32(+) cells coexpressed PD-1 and were enriched within T follicular helper (Tfh) cells. We next investigated the role of LN CD32(+) CD4 T cells in the HIV reservoir. Total HIV DNA was enriched in CD32(+) and PD-1(+) CD4 T cells compared to CD32(−) and PD-1(−) cells in both viremic and treated individuals, but there was no difference between CD32(+) and PD-1(+) cells. There was no enrichment of latently infected cells with inducible HIV-1 in CD32(+) versus PD-1(+) cells in antiretroviral therapy (ART)-treated individuals. HIV-1 transcription was then analyzed in LN memory CD4 T cell populations sorted on the basis of CD32 and PD-1 expression. CD32(+) PD-1(+) CD4 T cells were significantly enriched in cell-associated HIV RNA compared to CD32(−) PD-1(−) (averages of 5.2-fold in treated individuals and 86.6-fold in viremics), CD32(+) PD-1(−) (2.2-fold in treated individuals and 4.3-fold in viremics), and CD32(−) PD-1(+) (2.2-fold in ART-treated individuals and 4.6-fold in viremics) cell populations. Similar levels of HIV-1 transcription were found in CD32(+) PD-1(−) and CD32(−) PD-1(+) CD4 T cells. Interestingly, the proportion of CD32(+) and PD-1(+) CD4 T cells negatively correlated with CD4 T cell counts and length of therapy. Therefore, the expression of CD32 identifies, independently of PD-1, a CD4 T cell population with persistent HIV-1 transcription and coexpression of CD32 and PD-1, the CD4 T cell population with the highest levels of HIV-1 transcription in both viremic and treated individuals. IMPORTANCE The existence of long-lived latently infected resting memory CD4 T cells represents a major obstacle to the eradication of HIV infection. Identifying cell markers defining latently infected cells containing replication-competent virus is important in order to determine the mechanisms of HIV persistence and to develop novel therapeutic strategies to cure HIV infection. We provide evidence that PD-1 and CD32 may have a complementary role in better defining CD4 T cell populations infected with HIV-1. Furthermore, CD4 T cells coexpressing CD32 and PD-1 identify a CD4 T cell population with high levels of persistent HIV-1 transcription.
format Online
Article
Text
id pubmed-6158413
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-61584132018-10-12 CD32(+) and PD-1(+) Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals Noto, Alessandra Procopio, Francesco A. Banga, Riddhima Suffiotti, Madeleine Corpataux, Jean-Marc Cavassini, Matthias Riva, Agostino Fenwick, Craig Gottardo, Raphael Perreau, Matthieu Pantaleo, Giuseppe J Virol Pathogenesis and Immunity A recent study conducted in blood has proposed CD32 as the marker identifying the “elusive” HIV reservoir. We have investigated the distribution of CD32(+) CD4 T cells in blood and lymph nodes (LNs) of HIV-1-uninfected subjects and viremic untreated and long-term-treated HIV-1-infected individuals and their relationship with PD-1(+) CD4 T cells. The frequency of CD32(+) CD4 T cells was increased in viremic compared to treated individuals in LNs, and a large proportion (up to 50%) of CD32(+) cells coexpressed PD-1 and were enriched within T follicular helper (Tfh) cells. We next investigated the role of LN CD32(+) CD4 T cells in the HIV reservoir. Total HIV DNA was enriched in CD32(+) and PD-1(+) CD4 T cells compared to CD32(−) and PD-1(−) cells in both viremic and treated individuals, but there was no difference between CD32(+) and PD-1(+) cells. There was no enrichment of latently infected cells with inducible HIV-1 in CD32(+) versus PD-1(+) cells in antiretroviral therapy (ART)-treated individuals. HIV-1 transcription was then analyzed in LN memory CD4 T cell populations sorted on the basis of CD32 and PD-1 expression. CD32(+) PD-1(+) CD4 T cells were significantly enriched in cell-associated HIV RNA compared to CD32(−) PD-1(−) (averages of 5.2-fold in treated individuals and 86.6-fold in viremics), CD32(+) PD-1(−) (2.2-fold in treated individuals and 4.3-fold in viremics), and CD32(−) PD-1(+) (2.2-fold in ART-treated individuals and 4.6-fold in viremics) cell populations. Similar levels of HIV-1 transcription were found in CD32(+) PD-1(−) and CD32(−) PD-1(+) CD4 T cells. Interestingly, the proportion of CD32(+) and PD-1(+) CD4 T cells negatively correlated with CD4 T cell counts and length of therapy. Therefore, the expression of CD32 identifies, independently of PD-1, a CD4 T cell population with persistent HIV-1 transcription and coexpression of CD32 and PD-1, the CD4 T cell population with the highest levels of HIV-1 transcription in both viremic and treated individuals. IMPORTANCE The existence of long-lived latently infected resting memory CD4 T cells represents a major obstacle to the eradication of HIV infection. Identifying cell markers defining latently infected cells containing replication-competent virus is important in order to determine the mechanisms of HIV persistence and to develop novel therapeutic strategies to cure HIV infection. We provide evidence that PD-1 and CD32 may have a complementary role in better defining CD4 T cell populations infected with HIV-1. Furthermore, CD4 T cells coexpressing CD32 and PD-1 identify a CD4 T cell population with high levels of persistent HIV-1 transcription. American Society for Microbiology 2018-09-26 /pmc/articles/PMC6158413/ /pubmed/29976671 http://dx.doi.org/10.1128/JVI.00901-18 Text en Copyright © 2018 Noto et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Pathogenesis and Immunity
Noto, Alessandra
Procopio, Francesco A.
Banga, Riddhima
Suffiotti, Madeleine
Corpataux, Jean-Marc
Cavassini, Matthias
Riva, Agostino
Fenwick, Craig
Gottardo, Raphael
Perreau, Matthieu
Pantaleo, Giuseppe
CD32(+) and PD-1(+) Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals
title CD32(+) and PD-1(+) Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals
title_full CD32(+) and PD-1(+) Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals
title_fullStr CD32(+) and PD-1(+) Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals
title_full_unstemmed CD32(+) and PD-1(+) Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals
title_short CD32(+) and PD-1(+) Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals
title_sort cd32(+) and pd-1(+) lymph node cd4 t cells support persistent hiv-1 transcription in treated aviremic individuals
topic Pathogenesis and Immunity
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158413/
https://www.ncbi.nlm.nih.gov/pubmed/29976671
http://dx.doi.org/10.1128/JVI.00901-18
work_keys_str_mv AT notoalessandra cd32andpd1lymphnodecd4tcellssupportpersistenthiv1transcriptionintreatedaviremicindividuals
AT procopiofrancescoa cd32andpd1lymphnodecd4tcellssupportpersistenthiv1transcriptionintreatedaviremicindividuals
AT bangariddhima cd32andpd1lymphnodecd4tcellssupportpersistenthiv1transcriptionintreatedaviremicindividuals
AT suffiottimadeleine cd32andpd1lymphnodecd4tcellssupportpersistenthiv1transcriptionintreatedaviremicindividuals
AT corpatauxjeanmarc cd32andpd1lymphnodecd4tcellssupportpersistenthiv1transcriptionintreatedaviremicindividuals
AT cavassinimatthias cd32andpd1lymphnodecd4tcellssupportpersistenthiv1transcriptionintreatedaviremicindividuals
AT rivaagostino cd32andpd1lymphnodecd4tcellssupportpersistenthiv1transcriptionintreatedaviremicindividuals
AT fenwickcraig cd32andpd1lymphnodecd4tcellssupportpersistenthiv1transcriptionintreatedaviremicindividuals
AT gottardoraphael cd32andpd1lymphnodecd4tcellssupportpersistenthiv1transcriptionintreatedaviremicindividuals
AT perreaumatthieu cd32andpd1lymphnodecd4tcellssupportpersistenthiv1transcriptionintreatedaviremicindividuals
AT pantaleogiuseppe cd32andpd1lymphnodecd4tcellssupportpersistenthiv1transcriptionintreatedaviremicindividuals